Thinkresearch
Killing Cancer: Immunotherapy and Genomics
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:34:12
- Mas informaciones
Informações:
Sinopsis
"I treat pancreatic cancer and only 1% of those patients respond and the rest don't," says Osama Rahma, principal investigator at the Center for Immuno-Oncology and Gastroenterology Cancer Center at Dana-Farber Cancer Institute. Rahma discusses his research in cancer immunotherapy and his development of novel immunotherapy drugs.